Published in J Virol on July 01, 1992
Binding of the Src SH2 domain to phosphopeptides is determined by residues in both the SH2 domain and the phosphopeptides. Mol Cell Biol (1993) 1.45
Transformation by v-Src: Ras-MAPK and PI3K-mTOR mediate parallel pathways. Mol Biol Cell (1999) 1.35
Src SH2 arginine 175 is required for cell motility: specific focal adhesion kinase targeting and focal adhesion assembly function. Mol Cell Biol (2006) 1.11
Ras-independent transformation by v-Src. Proc Natl Acad Sci U S A (1997) 1.07
Functional role of GTPase-activating protein in cell transformation by pp60v-src. Mol Cell Biol (1993) 1.01
Aberrant protein phosphorylation at tyrosine is responsible for the growth-inhibitory action of pp60v-src expressed in the yeast Saccharomyces cerevisiae. Mol Biol Cell (1994) 0.92
The role of the Src homology domains in morphological transformation by v-src. Mol Biol Cell (1997) 0.81
Autophosphorylation is required for high kinase activity and efficient transformation ability of proteins encoded by host range alleles of v-src. J Virol (1994) 0.81
Host range restrictions of oncogenes: myc genes transform avian but not mammalian cells and mht/raf genes transform mammalian but not avian cells. Proc Natl Acad Sci U S A (1996) 0.79
Disease specificity of kinase domains: the src-encoded catalytic domain converts erbB into a sarcoma oncogene. Proc Natl Acad Sci U S A (1995) 0.76
Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell (1983) 25.46
Oncogenes and signal transduction. Cell (1991) 14.84
Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science (1991) 13.85
Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science (1991) 9.99
New procedure for DNA transfection with polycation and dimethyl sulfoxide. Mol Cell Biol (1984) 8.63
Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation. Cell (1987) 6.91
Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors. J Virol (1987) 6.88
Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src. Cell (1987) 5.84
Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases. Nature (1990) 5.57
Association between the PDGF receptor and members of the src family of tyrosine kinases. Cell (1990) 4.83
Identification of multiple novel polypeptide substrates of the v-src, v-yes, v-fps, v-ros, and v-erb-B oncogenic tyrosine protein kinases utilizing antisera against phosphotyrosine. Oncogene (1988) 4.25
Src homology region 2 domains direct protein-protein interactions in signal transduction. Proc Natl Acad Sci U S A (1990) 4.13
Normal rat cell lines deficient in nuclear thymidine kinase. Virology (1981) 4.13
Presence of an SH2 domain in the actin-binding protein tensin. Science (1991) 4.03
Cooperation between oncogenes. Cell (1991) 3.88
Transformation by Rous sarcoma virus: a cellular substrate for transformation-specific protein phosphorylation contains phosphotyrosine. Cell (1980) 3.70
Non-catalytic domains of cytoplasmic protein-tyrosine kinases: regulatory elements in signal transduction. Oncogene (1988) 3.70
Genetics of src: structure and functional organization of a protein tyrosine kinase. Curr Top Microbiol Immunol (1989) 3.03
Site-directed mutagenesis of the SH2- and SH3-coding domains of c-src produces varied phenotypes, including oncogenic activation of p60c-src. Mol Cell Biol (1990) 2.39
Tyrosine-specific protein phosphorylation is regulated by glycoprotein IIb-IIIa in platelets. Proc Natl Acad Sci U S A (1989) 2.35
Regulation of cell growth and transformation by tyrosine-specific protein kinases: the search for important cellular substrate proteins. Curr Top Microbiol Immunol (1983) 2.32
Site-directed mutagenesis of the src gene of Rous sarcoma virus: construction and characterization of a deletion mutant temperature sensitive for transformation. J Virol (1982) 2.20
Hormonal regulation of the Rous sarcoma virus src gene via a heterologous promoter defines a threshold dose for cellular transformation. Cell (1984) 2.17
The SH2 and SH3 domains of pp60src direct stable association with tyrosine phosphorylated proteins p130 and p110. EMBO J (1991) 2.07
Phosphorylation of tyrosine-416 is not required for the transforming properties and kinase activity of pp60v-src. Cell (1983) 1.98
Linker insertion-deletion mutagenesis of the v-src gene: isolation of host- and temperature-dependent mutants. J Virol (1989) 1.95
Biological techniques for avian sarcoma viruses. Methods Enzymol (1979) 1.67
Phosphotyrosine-containing proteins and expression of transformation parameters in cells infected with partial transformation mutants of Rous sarcoma virus. J Virol (1983) 1.56
A conserved domain regulates interactions of the v-fps protein-tyrosine kinase with the host cell. Proc Natl Acad Sci U S A (1987) 1.51
Mutations in src homology regions 2 and 3 of activated chicken c-src that result in preferential transformation of mouse or chicken cells. Proc Natl Acad Sci U S A (1990) 1.50
Deletions in the SH2 domain of p60v-src prevent association with the detergent-insoluble cellular matrix. Mol Cell Biol (1991) 1.46
Transformation by pp60src or stimulation of cells with epidermal growth factor induces the stable association of tyrosine-phosphorylated cellular proteins with GTPase-activating protein. Mol Cell Biol (1991) 1.42
Identification of an amino terminal domain required for the transforming activity of the Rous sarcoma virus src protein. Virology (1987) 1.41
A mutation in v-src that removes a single conserved residue in the SH-2 domain of pp60v-src restricts transformation in a host-dependent manner. J Virol (1989) 1.40
Identification of a 42-kilodalton phosphotyrosyl protein as a serine(threonine) protein kinase by renaturation. Mol Cell Biol (1990) 1.38
Src homology 2 domain deletion mutants of p60v-src do not phosphorylate cellular proteins of 120-150 kDa. Oncogene (1989) 1.09
Polymerase-defective mutant of the Bryan high-titer strain of Rous sarcoma virus. Nucleic Acids Res (1986) 1.08
Transduction of host cellular sequences by a retroviral shuttle vector. J Virol (1986) 1.02
Nonenzymatic phosphorylation of tyrosine and serine by ATP is catalyzed by manganese but not magnesium. J Biol Chem (1988) 0.97
Enhancement of virus yield of Rous sarcomas. Acta Unio Int Contra Cancrum (1959) 0.84
A host-dependent temperature-sensitive mutant of Rous sarcoma virus: evidence for host factors affecting transformation. Virology (1988) 0.81
A mutation in the catalytic domain of pp60v-src is responsible for the host- and temperature-dependent phenotype of the Rous sarcoma virus mutant tsLA33-1. Virology (1992) 0.78
The fission yeast cdc18+ gene product couples S phase to START and mitosis. Cell (1993) 6.25
Rous sarcoma virus: a function required for the maintenance of the transformed state. Nature (1970) 5.66
Transformation by Rous sarcoma virus: effects of src gene expression on the synthesis and phosphorylation of cellular polypeptides. Proc Natl Acad Sci U S A (1979) 4.18
Src homology region 2 domains direct protein-protein interactions in signal transduction. Proc Natl Acad Sci U S A (1990) 4.13
The a subunit in the RNA of transforming avian tumor viruses. I. Occurrence in different virus strains. II. Spontaneous loss resulting in nontransforming variants. Virology (1972) 3.95
Glycoprotein components of avian and murine RNA tumor viruses. Virology (1970) 3.92
Transformation by Rous sarcoma virus: a cellular substrate for transformation-specific protein phosphorylation contains phosphotyrosine. Cell (1980) 3.70
Specific RNA sequences and gene products of MC29 avian acute leukemia virus. Proc Natl Acad Sci U S A (1978) 3.22
Proposal for naming host cell-derived inserts in retrovirus genomes. J Virol (1981) 3.18
Temperature-dependent alterations in sugar transport in cells infected by a temperature-sensitive mutant of Rous sarcoma virus. Proc Natl Acad Sci U S A (1971) 2.83
Cell cycle tyrosine phosphorylation of p34cdc2 and a microtubule-associated protein kinase homolog in Xenopus oocytes and eggs. Mol Cell Biol (1991) 2.69
Cell-free translation of virion RNA from nondefective and transformation-defective Rous sarcoma viruses. J Virol (1976) 2.68
A strain of Fujinami sarcoma virus which is temperature-sensitive in protein phosphorylation and cellular transformation. Cell (1980) 2.61
Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity. J Biol Chem (1995) 2.55
Tyrosine-specific protein phosphorylation is regulated by glycoprotein IIb-IIIa in platelets. Proc Natl Acad Sci U S A (1989) 2.35
Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis. Brain Pathol (1996) 2.27
Phorbol ester and diacylglycerol induce protein phosphorylation at tyrosine. Nature (1984) 2.21
Protein phosphorylation at tyrosine is induced by the v-erbB gene product in vivo and in vitro. Cell (1985) 2.16
Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. Proc Natl Acad Sci U S A (1994) 2.14
Hypoproteinemia predicts acute respiratory distress syndrome development, weight gain, and death in patients with sepsis. Ibuprofen in Sepsis Study Group. Crit Care Med (2000) 2.10
Structure and function of Cdc6/Cdc18: implications for origin recognition and checkpoint control. Mol Cell (2000) 2.07
Platelet tyrosine-specific protein phosphorylation is regulated by thrombin. Mol Cell Biol (1988) 2.01
Suppression of c-ras transformation by GTPase-activating protein. Nature (1990) 1.96
Linker insertion-deletion mutagenesis of the v-src gene: isolation of host- and temperature-dependent mutants. J Virol (1989) 1.95
Novel yeast protein kinase (YPK1 gene product) is a 40-kilodalton phosphotyrosyl protein associated with protein-tyrosine kinase activity. Mol Cell Biol (1990) 1.93
The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination. Oncogene (2000) 1.89
Structural basis for the interaction of Ras with RalGDS. Nat Struct Biol (1998) 1.80
Schwann cells from neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphological changes. Oncogene (1995) 1.78
Transformation-defective mutants of avian sarcoma viruses: the genetic relationship between conditional and nonconditional mutants. Virology (1976) 1.75
Protein-tyrosine kinase activity in Saccharomyces cerevisiae. Science (1986) 1.68
Phosphorylation of talin at tyrosine in Rous sarcoma virus-transformed cells. Mol Cell Biol (1987) 1.65
Membrane association of a 36,000-dalton substrate for tyrosine phosphorylation in chicken embryo fibroblasts transformed by avian sarcoma viruses. J Cell Biol (1983) 1.65
Myocardial bridge as a cause of thrombus formation and myocardial infarction in a young athlete. Clin Cardiol (1997) 1.64
Inactivation of the NF1 gene in human melanoma and neuroblastoma cell lines without impaired regulation of GTP.Ras. Proc Natl Acad Sci U S A (1993) 1.55
Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region. Proc Natl Acad Sci U S A (1996) 1.54
Agglutination of cells transformed by Rous sarcoma virus by wheat germ agglutinin and concanavalin A. Nat New Biol (1972) 1.53
A conserved domain regulates interactions of the v-fps protein-tyrosine kinase with the host cell. Proc Natl Acad Sci U S A (1987) 1.51
Tyrosine phosphorylation of a 50K cellular polypeptide associated with the Rous sarcoma virus transforming protein pp60src. Mol Cell Biol (1982) 1.49
Nucleotidylation, not phosphorylation, is the major source of the phosphotyrosine detected in enteric bacteria. J Bacteriol (1989) 1.42
Role of the tuberous sclerosis gene-2 product in cell cycle control. Loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase. J Biol Chem (1997) 1.42
Identification of a 42-kilodalton phosphotyrosyl protein as a serine(threonine) protein kinase by renaturation. Mol Cell Biol (1990) 1.38
Mutants of Rous sarcoma virus with extensive deletions of the viral genome. Virology (1979) 1.37
Ubiquitin-dependent degradation of active Src. Curr Biol (1999) 1.36
Transformation by v-Src: Ras-MAPK and PI3K-mTOR mediate parallel pathways. Mol Biol Cell (1999) 1.35
env Gene of Rous sarcoma virus: identification of the gene product by cell-free translation. J Virol (1980) 1.28
Thrombin stimulates the activities of multiple previously unidentified protein kinases in platelets. J Biol Chem (1989) 1.27
Cell-free translation of avian erythroblastosis virus RNA. J Virol (1980) 1.20
cAMP-dependent protein kinase A is required for Schwann cell growth: interactions between the cAMP and neuregulin/tyrosine kinase pathways. J Neurosci Res (1997) 1.18
Viral transformation of rat myoblasts: effects on fusion and surface properties. Dev Biol (1976) 1.17
Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin. Hum Mol Genet (2001) 1.16
Cellular localization of c-fps gene product NCP98. J Virol (1984) 1.16
Overexpression of the yeast MCK1 protein kinase suppresses conditional mutations in centromere-binding protein genes CBF2 and CBF5. Mol Gen Genet (1995) 1.15
Casein kinase II catalyzes tyrosine phosphorylation of the yeast nucleolar immunophilin Fpr3. J Biol Chem (1997) 1.15
Ras-independent activation of Ral by a Ca(2+)-dependent pathway. Curr Biol (1998) 1.14
Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function. Mol Cell Biol (1994) 1.14
Co-localization of the TSC2 product tuberin with its target Rap1 in the Golgi apparatus. Oncogene (1996) 1.13
Ras-specific exchange factor GRF: oligomerization through its Dbl homology domain and calcium-dependent activation of Raf. Mol Cell Biol (1999) 1.12
Loss of tuberin, the tuberous-sclerosis-complex-2 gene product is associated with angiogenesis. J Cutan Pathol (2001) 1.11
Shp-2 mediates v-Src-induced morphological changes and activation of the anti-apoptotic protein kinase Akt. Oncogene (2000) 1.08
Ras-independent transformation by v-Src. Proc Natl Acad Sci U S A (1997) 1.07
v-Src generates a p53-independent apoptotic signal. Mol Cell Biol (2000) 1.04
An amino-terminal amino acid affects the electrophoretic mobility of the HIV-1 nef protein. J Acquir Immune Defic Syndr (1992) 1.04
Yeast MCK1 protein kinase autophosphorylates at tyrosine and serine but phosphorylates exogenous substrates at serine and threonine. J Biol Chem (1993) 1.03
Arthroscopic surgery for the treatment of osteochondral chip fractures in the equine carpus. J Am Vet Med Assoc (1987) 1.03
Regulation of p21ras activity. Trends Genet (1992) 1.02
Viral transformation of chick myogenic cells. The relationship between differentiation and the expression of the SRC gene. Exp Cell Res (1979) 1.01
Cellular localization of the transforming protein of wild-type and temperature-sensitive Fujinami sarcoma virus. J Virol (1984) 0.98
Intracellular targeting of pp60src expression: localization of v-src to adhesion plaques is sufficient to transform chicken embryo fibroblasts. Oncogene (1992) 0.98
The tyrosine phosphorylation substrate p36 is developmentally regulated in embryonic avian limb and is induced in cell culture. J Cell Biol (1986) 0.98
pp60v-src tyrosine kinase is expressed and active in sarcoma-free avian embryos microinjected with Rous sarcoma virus. Proc Natl Acad Sci U S A (1988) 0.97
Nonenzymatic phosphorylation of tyrosine and serine by ATP is catalyzed by manganese but not magnesium. J Biol Chem (1988) 0.97
Rapidly fatal infection with Ehrlichia chaffeensis. N Engl J Med (1999) 0.96
Assessing activities of blotted protein kinases. Methods Enzymol (1991) 0.95
Three-dimensional structure of the Ras-interacting domain of RalGDS. Nat Struct Biol (1997) 0.95
The 60-70S RNA of avian sarcoma and leukosis viruses--distribution of class a and b subunits. Bibl Haematol (1973) 0.94
Tuberous sclerosis in a 20-week gestation fetus: immunohistochemical study. Acta Neuropathol (1997) 0.93
Aberrant protein phosphorylation at tyrosine is responsible for the growth-inhibitory action of pp60v-src expressed in the yeast Saccharomyces cerevisiae. Mol Biol Cell (1994) 0.92
Transformation by Rous sarcoma virus: effects of src-gene expression on the synthesis and phosphorylation of cellular polypeptides. Cold Spring Harb Symp Quant Biol (1980) 0.92
Arthroscopic anatomy of the intercarpal and radiocarpal joints of the horse. Equine Vet J (1985) 0.92
Transformation parameters of chick embryo fibroblasts transformed by Fujinami, PRCII, PRCII-p, and Y73 avian sarcoma viruses. Virology (1982) 0.91
Cas mediates transcriptional activation of the serum response element by Src. Mol Cell Biol (1999) 0.91
Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues. Am J Pathol (1997) 0.90
The yeast immunophilin Fpr3 is a physiological substrate of the tyrosine-specific phosphoprotein phosphatase Ptp1. J Biol Chem (1995) 0.89
Intracellular localization of pp60c-src in human platelets. Oncogene (1990) 0.88
Sequential modification of serines 621 and 624 in the Raf-1 carboxyl terminus produces alterations in its electrophoretic mobility. J Biol Chem (1997) 0.87
The role of nucleotide binding and hydrolysis in the function of the fission yeast cdc18(+) gene product. Genetics (1999) 0.85
Mck1, a member of the glycogen synthase kinase 3 family of protein kinases, is a negative regulator of pyruvate kinase in the yeast Saccharomyces cerevisiae. J Bacteriol (1997) 0.85
Alterations in the rap1 signaling pathway are common in human gliomas. Oncogene (1997) 0.85
Disruption of the caudal component of the reciprocal apparatus in two horses. J Am Vet Med Assoc (1991) 0.84
Long-term results and complications of proximal interphalangeal arthrodesis in horses. J Am Vet Med Assoc (1984) 0.84
Effect of intra-articular injection of orgotein and saline solution on equine synovia. Am J Vet Res (1982) 0.84
Generation of nondefective Rous sarcoma virus by asymmetric recombination between deletion mutants. J Virol (1980) 0.84
Reduced phosphotyrosine binding by the v-Src SH2 domain is compatible with wild-type transformation. Oncogene (1996) 0.83
Cross-sectional area of the aditus laryngis and rima glottidis before and after transection of the left recurrent laryngeal nerve in the horse. Am J Vet Res (1986) 0.81
The role of the Src homology domains in morphological transformation by v-src. Mol Biol Cell (1997) 0.81
Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas. Ann Neurol (1997) 0.81
Correlation between anion gap, blood L lactate concentration and survival in horses. Equine Vet J (1987) 0.81